U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152444) titled 'A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension' on Aug. 26.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of single and multiple ascending doses of QLS1410 in healthy Chinese adults and participants with mild essential hypertension
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Uncontrolled Hypertension
Intervention:
DRUG: QLS1410 (CYP11B2 inhibitor)
QLS1410 tablets
DRUG: placebo
Matching placebo tablets
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Qi...